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Abstract
Background: Despite increasing interest in possible differences in virulence and transmissibility between different
genotypes of M. tuberculosis, very little is known about how genotypes within a population change over decades, or about
relationships to HIV infection.
Methods and Principal Findings: In a population-based study in rural Malawi we have examined smears and cultures from
tuberculosis patients over a 20-year period using spoligotyping. Isolates were grouped into spoligotype families and
lineages following previously published criteria. Time trends, HIV status, drug resistance and outcome were examined by
spoligotype family and lineage. In addition, transmissibility was examined among pairs of cases with known epidemiological
contact by assessing the proportion of transmissions confirmed for each lineage, on the basis of IS6110 RFLP similarity of the
M tuberculosis strains. 760 spoligotypes were obtained from smears from 518 patients from 1986–2002, and 377
spoligotypes from cultures from 347 patients from 2005–2008. There was good consistency in patients with multiple
specimens. Among 781 patients with first episode tuberculosis, the majority (76%) had Lineage 4 (‘‘European/American’’)
strains; 9% had Lineage 3 (‘‘East-African/Indian’’); 8% Lineage 1 (‘‘Indo-Oceanic’’); and 2% Lineage 2 (‘‘East-Asian’’); others
unclassifiable. Over time the proportion of Lineage 4 decreased from .90% to 60%, with an increase in the other 3 lineages
(p,0.001). Lineage 1 strains were more common in those with HIV infection, even after adjusting for age, sex and year.
There were no associations with drug resistance or outcome, and no differences by lineage in the proportion of pairs in
which transmission was confirmed.
Conclusions: This is the first study to describe long term trends in the four M. tuberculosis lineages in a population. Lineage
4 has probably been longstanding in this population, with relatively recent introductions and spread of Lineages1–3,
perhaps influenced by the HIV epidemic.
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Introduction
The advent of molecular typing has provided tools for studying
the relative fitness and virulence of different strains of tuberculosis
[1]. Large outbreaks, and clusters of identical strains, have been
taken as suggestive of virulence, and certain strains have been
explored in animal or in vitro models [2,3]. The Beijing family of
strains has been most extensively investigated. While it is
increasing in some areas it is stable in others, and the results
from animal experiments of virulence are mixed [4,5,6].
Long term trends provide important evidence of relative fitness,
but such data are rare [7]. Whereas an outbreak of a single strain
could result from characteristics of the index patient – due to
mixing patterns, cavitatory or laryngeal disease, long periods
before treatment, and so on – long term trends in families of
strains within populations are more likely to reflect characteristics
of the strains themselves.
Most epidemiological studies have defined strains using IS6110
RFLP, which is estimated to have a half life of about 3.5 years [8,9].
This is ideal for contact tracing and outbreak studies, as
epidemiologically related individuals are likely to share the same
fingerprint. But for longer-term trends a molecular marker with a
relatively slow ‘‘molecular clock’’ is required. Spoligotyping
provides a suitable method, and families of related genotypes have
already been described [10]. Each spoligotype can have a range of
RFLP fingerprints, so spoligotype clusters do not necessarily
representcloseepidemiological linkage,andincreasesinaparticular
spoligotype in a population are unlikely to result from single
outbreak events. Spoligotyping has the added advantage of being
PCR-based. It can therefore be used in the absence of a live culture.
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described, based on deletions and single nucleotide polymorphisms
(SNPs). Some of the families described by spoligotype fit closely
with these lineages, whereas Lineage 4 contains several related
spoligotype families [1].
In the Karonga Prevention Study in northern Malawi we have
already described RFLP based clustering results from 1996
onwards [11,12]. Using stored sputum smears, and more recent
samples, we now characterise the strains present in the population
over a 20 year period from 1986, examining trends and patient
characteristics over time.
Methods
Ethics statement: The studies were approved by the Health
Sciences Research Committee, Malawi and by the ethics
committee of the London School of Hygiene and Tropical
Medicine, UK. The specimens were collected as part of routine
tuberculosis clinical activities. HIV testing was performed with
counselling and consent. Written consent was sought for all later
studies, including the contact study.
The Lepra Evaluation Project/Karonga Prevention Study has
been carrying out population-based studies of mycobacterial
disease in Karonga District, northern Malawi since the 1980s.
Information on all tuberculosis cases diagnosed in the district since
1986 has been collected. Project staff are based at peripheral
clinics and in the district hospital and screen individuals with
chronic cough and other symptoms suggestive of tuberculosis.
Diagnosed patients are interviewed, and since 1988 have been
HIV tested, after counselling, and if consent is given. Procedures
have been described in detail elsewhere [13]. The population of
the district is now around 250,000, with 100–150 microbiologi-
cally confirmed tuberculosis cases diagnosed each year.
At least three smears are examined per patient with fluorescence
microscopy, and positives confirmed on light microscopy. Since
1986 cultures have been sent to the UK for species identification
and drug resistance testing. RFLP fingerprinting has been done in
the UK on specimens from 1996, and spoligotyping on all cultures
from late 2005 onwards [11].
Over the course of the study, smears have been stored. Many
have subsequently been lost, possibly when the new laboratory was
built, but 555 positive smears from the period 1986–96 remain.
These were not a true random sample, but were not selected for
any particular purpose so should be representative of circulating
strains from the whole district.
Spoligotyping [14] was performed on these archived smears
using the van der Zanden protocol [15] with Chelex extraction of
the DNA, and using neat, 1:10 and 1:100 diluted DNA. To check
the reliability of results from stored smears, spoligotyping was also
carried out on more recent smears from 2002. Many patients had
multiple smears, and these were processed independently, blind to
the patient’s identity. Spoligotypes were also done on all cultures
received in the laboratory from late 2005–8. Therefore spoligotype
results were available from unselected patients from throughout
Karonga District from 1986–2008 (figure 1).
Spoligotyping results were scanned and analysed using BioNu-
merics software (Applied Maths, Belgium) and checked individu-
ally by eye. Results were described by the octal code [16], and
classified by comparison with the SpolDB4 database [10]. Results
were also grouped into lineages based on the spoligotype [1,17].
Analyses assessed the trends over time in lineages, spoligotype
families, and spoligotypes. The characteristics of patients within
each group were compared. Whether there was any evidence of
variation by lineage or spoligotype was assessed overall (by chi
squared test) and any associations found were assessed in more
detail, using logistic regression to adjust for confounders.
As a further test of whether the lineages convey different
characteristics, data on transmission in contact pairs were re-
analysed. We have previously identified 143 pairs of individuals in
which the first case had smear positive TB, and the second case
was linked epidemiologically [18]. Epidemiological linkage was
established by asking patients about contacts with previous
individuals with tuberculosis and from long-standing epidemio-
logical studies that allow close-relatives and those living in the
same household to be identified. This is described in detail
elsewhere [18]. We have shown that whether the second case had
apparently acquired their M. tuberculosis from transmission from
the first case – based on RFLP matching – depended on closeness
of contact and HIV status of the first case. We defined
transmission as confirmed if the second case in the pair had an
identical RFLP pattern to the first, or if the pattern differed by 1–4
bands and the later strain was the first example of the new pattern
in the population. We now categorise the strain of the first case by
lineage, using data on individuals for whom both RFLP and
spoligotype were available, and inferring the lineage for closely
related RFLP patterns.
Results
Smears from 1986–1996, and 2002
Overall, spoligotype patterns were obtained from 760 smears
from 518 different patients, some with multiple episodes of disease.
153 patients had multiple results from the same episode of disease,
from smears taken within 3 months of each other (75 pairs, 40
triplets, 12 sets of four, one set of 5 and one of 6). Overall 128/153
(83.7%) had identical patterns among their multiple results. Only 5
Figure 1. Timeline and source of isolates.
doi:10.1371/journal.pone.0012259.g001
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triplet, 1 quadruplet) suggesting mislabelling, cross-contamination
or mixed infection. The quadruplet had 2 slides showing one
pattern and 2 another, suggesting mixed infection. Other patterns
differed by one spacer (15 patients) 2 spacers (3), 3 spacers (1) or 4
spacers (1).
For subsequent analyses, for those with more than one smear,
the more common pattern was chosen where possible. For those
patients with results with similar patterns that were equally com-
mon, the pattern with more spacers was chosen, as the spoligo-
type patterns with different dilutions suggested that the main error
was failure of amplification or hybridization to the membrane
(especially for spacer 15). Four individuals were dropped from the
analysis because the most likely pattern could not be inferred.
Cultures from 2005–8
Overall 377 spoligotypes were available from 347 patients. 29
patients had multiple specimens (28 pairs, one triplet). Only one
pair had completely different patterns, and was dropped. One pair
had one spacer different. Two further pairs had different patterns
(one had one spacer different, one completely different) but after
more than 6 months.
Multiple episodes
12 patients had results from more than one episode of TB. 6 had
identical patterns (including one patient with three episodes), 3 had
slight differences (one or two spacers) and 3 had completely
different patterns.
Patterns
To examine patterns and trends each patient was only included
once, for their first episode of disease, and any patients with a
history of previous TB were excluded. This left 781 patients.
The definition of strain families in the SpolDB4 data base is not
clear: some rules are not mutually exclusive [19], and many of the
patterns seen in this population have not previously been
described. We have based our classification on the definitions, as
shown in table 1. It is clear that some families are very similar (X
and T for example), and all these related spoligotypes (LAM, H, T,
X) are part of Lineage 4. Lineage 1 strains are equivalent to the
spoligotype family EAI (East African Indian), Lineage 2 includes
Beijing strains; Lineage 3 is equivalent to CAS [1,17].
Three quarters of the strains came from Lineage 4, with most
being LAM. Overall 46% of patients had spoligotypes consistent
with LAM11, of which half had spoligotype ST59 (in which all
spacers are present other than those that define the LAM11
pattern). The other common spoligotypes (those present in more
than 10 individuals) are shown in table 2.
Trends over time
Trends over time were examined by lineage, family and for the
common spoligotype patterns. Time was divided into four periods
to give roughly equal numbers of specimens: 1986–91, 1992–96,
2002–5, 2006–8.
There was marked variation over time in the proportion of TB
due to the different lineages (figure 2), with a decrease in Lineage 4
(from more than 90% of those with identifiable lineages in the
early years, to 60% in the most recent period) and an increase in
the other 3 lineages (p,0.001).
Spoligotypes in Lineage 2 other than Beijing are not clearly
defined [17], so we have only considered Beijing strains. All the
Beijing strains had the identical, typical spoligotype. None were
found among 157 isolates from 1986–1990, with the first isolate in
1991. The proportion increased up to 4.3% (p trend=0.003).
The increase in Lineage 3 was due to an increase in the family
CAS1-Kili, and most (44/49) of the CAS1-Kili strains were a
Table 1. Frequency of different Lineages and spoligotype families.
Lineage/Family Octal code Frequency %
Lineage 1 (Indo-Oceanic) 61 7.8
E A I *********413*** 6 1 7 . 8
Lineage 2 (East Asia) 20 2.6
Beijing 0 0 0 0 0 0 0 0 0 0 0 3 7 7 1 20 2.6
Lineage 3 (East Africa/India) 70 9.0
CAS1-Kili * 0 3 3 * * 4 0 0 0 0 1 * * * 49 6.3
C A S 1 o t h e r *03****40003*** 2 1 2 . 7
Lineage 4 (European-American) 593 75.9
H **********20*** 1 1 1 . 4
L A M 1 1 ******606060*** 3 6 2 4 6 . 4
LAM other * * * * * * 6 0 7 7 6 0 * * * 41 5.3
T 1 777777777760771 5 0 6 . 4
T o t h e r *******77760*** 6 0 7 . 7
X *****6777760*** 1 9 2 . 4
Unclassified * * * * * * * * * * 4 0 * * * 50 6.4
Lineage unclear 37 4.7
The definitions of spoligotype family are based on those given in SpolDB4 [21], and are shown by octal code. Only those parts of the code that define the spoligotype
are shown. Other positions are shown by ‘‘*’’.
EAI=East African Indian.
CAS=Central Asian.
LAM=Latin American Mediterranean.
doi:10.1371/journal.pone.0012259.t001
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patterns. The first isolate of spoligotype ST21 was from 1987,
and the proportion increased from 1% to 12% (p trend,0.001).
The Lineage 1/EAI strains were more varied: 10 different
spoligotypes. The two most common patterns are shown in table 2.
Spoligotype ST129 increased over time (p,0.001), and 2 closely
related patterns (3 isolates) were also found in the later years.
Spoligotype ST806 showed no evidence of increase, and nor did a
closely related pattern found in 9 patients. Excluding spoligotype
ST129, there was still some evidence of an increase over time in
EAI.
Lineage 4 decreased over time. The proportion of LAM11
strains decreased in the last period, although the proportion of
spoligotype ST59 increased over time. This may be an artefact, as
the spoligotype that we have designated ST59c, which differs from
59 only in the absence of spacer 15 was found only up to 1994
(p,0.001), and it was previously noted that hybridisation of spacer
15 was not consistent. Another variant of the pattern, which we
have called spoligotype ST59d, was not found after 1996 (p
trend=0.001).
The distribution of patients by age and sex was similar in the
different lineages. None of the trends with time were changed by
adjusting for age, sex or HIV status.
Trends with HIV
HIV status was available for 615 patients: 47% were HIV
positive. The proportion HIV positive varied by lineage
(p=0.007), with the highest proportion positive in Lineage 1
(68%). The association between lineage and HIV status persisted
but was less strong after adjusting for year, age and sex (adjusted
odds ratio for lineage 1 compared to lineage 4=2.10, 95% CI
1.05–4.21, table 3). The only individual spoligotype pattern that
was associated with HIV status was the most common Lineage 1
spoligotype, ST129, with 17/21 (81%) HIV positive. This
association was less strong, but persisted after adjusting for age,
sex and year.
Table 2. Trends over time for lineages, spoligotype families and the commoner spoligotypes.
Lineage Family Spoligotype STno 1986–91 1992–96 2001–5 2006–8 Total
n% n% n% n%
Lineage 1 (EAI) 8 3.9 4 2.2 12 8.5 37 14.6 61
700777747413771 129 1 0.5 2 1.1 3 2.1 18 7.1 24
757777777413731 806 4 2.0 1 0.6 2 1.4 4 1.6 11
Lineage 2
000000000003771 1 1 0.5 2 1.1 6 4.3 11 4.3 20
Lineage 3 (CAS) 8 3.9 8 4.4 16 11.4 38 15.0 70
CAS1-Kili 2 1.0 2 1.1 11 7.8 34 13.4 49
703377400001771 21 2 1.0 1 0.6 10 7.1 31 12.2 44
CAS1 other 6 2.9 6 3.3 5 3.6 4 1.6 21
Lineage 4 175 85.8 159 87.4 106 75.2 153 60.2 593
H2 1.0 3 1.7 2 1.4 4 1.6 11
LAM11 105 51.5 91 50.0 74 52.5 92 36.2 362
777777606060771 59 32 15.7 24 13.2 35 24.8 60 23.6 151
777777606060731 815 13 6.4 7 3.9 10 7.1 2 0.8 32
377777606060771 59a 7 3.4 3 1.7 8 5.7 1 0.4 19
577777606060771 59b 8 3.9 3 1.7 5 3.6 11 4.3 27
777767606060771 59c 8 3.9 12 6.6 0 0.0 0 0.0 20
777707606060771 59d 7 3.4 4 2.2 0 0.0 0 0.0 11
077777606060671 1468 5 2.5 3 1.7 1 0.7 2 0.8 11
LAM other 10 4.9 7 3.9 7 5.0 17 6.7 41
777777607760771 42 3 1.5 6 3.3 3 2.1 2 1.8 14
677777607760771 20 2 1.0 1 0.6 2 1.4 9 3.5 14
T1 777777777760771 53 12 5.9 15 8.2 12 8.5 11 4.3 50
T other 21 10.3 18 9.9 7 5.0 14 5.5 60
X9 4.4 6 3.3 0 0.0 4 1.6 19
Unclassified 16 9.1 19 12.0 4 3.8 11 7.2 50
Unclassified 12 5.9 9 5.0 1 0.7 15 5.9 37
Total 204 100 182 100 141 100 254 100 781
STno.=Spoligotype numbers from the SpolDB4 database. The strains numbered here 59a–d are not found on the database.
Note that only the more common spoligotype patterns are shown for each spoligotype family. For example there were 49 individuals with CAS1-Kili, of which 44 had
spoligotype 21, and 5 had other spoligotypes (not shown).
doi:10.1371/journal.pone.0012259.t002
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Overall 39/536 (7.3%) isolates with results available were
resistant to isoniazid and 4/536 (0.75%) were resistant to
rifampicin. The four patients with multidrug resistant TB were
diagnosed in 1986, 1993, 1994 and 2008, and had four different
spoligotype patterns. There was no evidence that the proportion of
isolates that were isoniazid resistant varied by lineage, spoligotype
or spoligotype family more than would be expected by chance.
None of the 16 Beijing or 19 spoligotype ST129 strains tested had
any drug resistance.
Outcome
Outcome was recorded for 769 individuals: 556 were cured, 125
died, 1 had treatment failure, 55 were lost to follow-up and 32
transferred out. After excluding those who were lost, transferred or
failed, the case fatality rate was 18.4%. Mortality was similar in the
different lineages (8/55 (14.6%) in lineage 1, 4/17 (23.5%) in 2,
14/63 (22.2%) in 3, 93/512 (18.2%) in 4, p=0.7). The mortality
was higher in those who were HIV positive, older, had isoniazid
resistance, and in earlier years. After adjusting for these factors
none of the lineages or strains were significantly associated with
mortality, but numbers were small (403 cases and 45 deaths with
data on HIV and isoniazid resistance).
Transmission in contact pairs
In order to define the lineage for the contact pairs we first linked
the RFLP patterns to the spoligotype. Assuming that other patients
in the population with the same RFLP would have the same
spoligotype, we inferred the spoligotype pattern for 100 of the
RFLP-defined strains from the first cases in the pairs. For the
remaining cases, the likely lineage was inferred based on similarity
to other RFLP-defined strains in the population. In this way the
likely lineage was derived for all but 14 of the 143 patients. We
used our previous definition of confirmed transmission. There was
no difference by lineage of the first case in the proportion of pairs
in which transmission was confirmed: 7/22 (31.8%) Lineage 1, 2/
7 (28.6%) Lineage 2, 7/16 (43.8%) Lineage 3, 29/84 (34.5%)
Lineage 4, (p=0.9). There was still no difference after adjusting for
closeness of contact or HIV status of the first case.
Discussion
This small rural area of northern Malawi has examples of all the
Lineages of M. tuberculosis. The early predominance of Lineage 4
has decreased over time, with concomitant increases in the other 3
Lineages, in particular of spoligotypes ST1 (Beijing), ST21 and
ST129. The Beijing genotype is very widespread, making up the
majority of tuberculosis cases in some parts of the world, and
increasing in others [4]. In some countries, notably Eastern
Europe, it is associated with drug resistance [4]. We have
previously reported an increase in Beijing genotype in this
population, based on RFLP patterns, over a shorter time period
[20]. This study confirms this trend, and the lack of drug resistance
in this setting, but also suggests that the proportion of tuberculosis
due to the Beijing genotype has now stabilised at 4%.
Spoligotype ST21, a CAS strain, has been previously recorded
(143 examples in the SpolDB4 database [21]) in Europe, the USA,
eastern and southern Africa, and the Middle East. Spoligotype
ST129, an EAI strain, has been recorded less frequently (19 listed
in the SpolDB4 database), from Africa, Brazil, USA and Europe.
Both spoligotypes ST21 and ST129 had previously been noted to
be the spoligotypes of two of the common RFLP-defined clusters
identified in the Karonga population [22].
Figure 2. Proportion of tuberculosis due to the different lineages over time. (Isolates that could not be assigned to a lineage are excluded).
doi:10.1371/journal.pone.0012259.g002
Table 3. Association of HIV status and lineage.
Lineage HIV+ (n/N) % OR
OR adjusted for
age, sex, year
1 (EAI) 34/50 68.0 2.76 (1.48–5.14) 2.10 (1.05–4.21)
2 (Beijing) 7/17 41.2 0.91 (0.34–2.43) 0.51 (0.18–1.43)
3 (CAS) 29/55 52.7 1.45 (0.83–2.54) 0.94 (0.50–1.74)
4 201/462 43.5 ref ref
OR=odds ratio.
doi:10.1371/journal.pone.0012259.t003
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common in each time period. The increase over time was
probably an artefact due to failures of hybridisation of spacer 15 in
some of the long stored samples. We have previously noted this as
the most common spoligotype in our population [22], and it is
common elsewhere in the region, particularly in Zambia and
Zimbabwe [23,24].
The results suggest that Lineage 4, and particularly strains with
spoligotypes similar to ST59, have been well established in the
area for a long time. The Beijing strains appear to be the most
recent arrivals. There was evidence that Lineage 1 and 3 strains
were already present in the 1980s. It is not clear if the increases are
the result of chance spread following introduction or whether they
represent any selective advantage. The changes may simply reflect
increasing migration and travel leading to opportunities for
exposure to different strains. It is intriguing that Lineage 1 strains
were more commonly found in those who were HIV positive. This
could suggest that the strains were less able to cause disease in
those who are not immunocompromised. Lineage 1 is the
predominant Lineage in South India, and it has been noted that
southern Indian strains were less virulent in animal experiments
[25]. In our study there were no clear associations between lineage
or strain and outcome or transmission.
This is the first study to describe trends in the four M. tuberculosis
lineages over many years in a population. We have seen clear
changes in the genotype distribution, possibly in part due to the
HIV epidemic.
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